Pfizer

By Aditi Pai April 30, 2015
A majority of consumers are willing to take greater ownership of their health, according to a survey of 2,024 US adults and 516 primary care physicians. The survey was conducted by Ipsos in collaboration with the National Council on Patient Information and Education (NCPIE) and Pfizer. The survey found that 64 percent of respondents said they could be making more decisions about their health and...
By Aditi Pai April 8, 2015
Vancouver-based Ayogo has raised $2.5 million from Merck Global Health Innovation Fund (GHI), Excel Venture Management, and 7Wire Ventures for it's patient engagement offering, an app called Empower. The app, designed for providers and pharma companies, helps patients with chronic conditions stick to their care plans. Patients can use the app to set their own goals, track their health and...
By Jonah Comstock April 6, 2015
Misfit Flash, one of the devices that will be used in the study. AARP has launched a new research initiative, called Project Catalyst, where the organization will work with partners including Pfizer, UnitedHealthcare, and Georgia Tech to promote an increased focus on users over 50 in digital health research and development. The first project of the new initiative, focused on sleep and activity...
By Jonah Comstock December 11, 2014
Exco InTouch, the clinical trial technology vendor best known for its large-scale COPD program with AstraZeneca and the NHS trusts in England, has raised $5 million (3.2 million pounds). The round was led by Albion Ventures, according to British news site HealthInvestor. Scottish Equity Partners, Exco's largest shareholder, also contributed to the round. The Nottingham, England-based company...
By Aditi Pai October 29, 2014
San Mateo-based startup Mousera raised $8.8 million from undisclosed investors, according to a report from MedCity News. The company cryptically states on its website that it's "accelerating medical advancement by bringing 21st century technology into living systems research". Although the company hasn't released investor names, former Pfizer CEO and Lux Capital Venture Partner Jeff Kindler was...
By Jonah Comstock October 27, 2014
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren't seeing downloads and usage on par with the apps from other industries. That's the conclusion of a new report from Research2Guidance (R2G), which analyzed more than 725 apps from 11 pharma companies. According to R2G, the top pharma companies have 65 apps in the Apple and...
By Jonah Comstock February 5, 2014
TapTrak's forthcoming clinical trials app. Medical micro-journaling startup tapTrak has formally hired pharma veteran Efren Olivares, a hire that signals the company's upcoming expansion into the pharma space. New York City-based tapTrak, which raised $390,000 in seed funding last July, began its life in 2011 as a consumer-focused quantified self app, to make it easy for people to track and...
By Aditi Pai January 9, 2014
Boston-based Akili Interactive Labs partnered with Pfizer to conduct a study of Akili's iOS-based game, Project Evo, in the hopes of using the game to detect indications of Alzheimer's in healthy individuals. The month-long study of 100 participants includes a mix of some who have risk markers of potentially developing Alzheimer's and some who do not. All participants will take the game home and...
By Neil Versel September 17, 2013
Humetrix's iBlueButton app won the ONC's Blue Button Mashup Challenge in January. With new, tougher HIPAA privacy regulations set to take effect in less than a week, the HHS Office for Civil Rights (OCR), which enforces the rules, is trying to educate consumers and healthcare entities alike about a longstanding but much-ignored policy. "There is a clear right [in the HIPAA privacy rule] not...
By Jonah Comstock June 27, 2013
Ayogo's Diabestes app for college students. Health gaming company Ayogo's CEO Michael Fergusson hinted at this week's Games for Health event in Boston that the company is working on a new game for a major pharmaceutical company, although he wasn't able to reveal any details. "I sure would like to show you this game but I didn't get clearance to show it. We're working with one of the five largest...

Editor's Pick